Journal of Neuroimmune Pharmacology 2017
Top Research Directions
The 3 research directions with Journal of Neuroimmune Pharmacology 2017 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Bridging the Cross Species Clinical Translation Gap | 1 | 100.0% |
| 2 | Principles of Protein Expression Analysis via Western Blotting | 1 | 100.0% |
| 3 | Targeting Alternative Pathological Pathways in Alzheimer's Disease | 1 | 100.0% |
Download all directions as CSV
Institutions
Institutions credited by Journal of Neuroimmune Pharmacology 2017 papers: a paper credits every institution named in its affiliations, once. 4 institutions share 1 credited papers.
| # | Institution | Papers | Share |
|---|---|---|---|
| 1 | 00thqtb16 | 1 | 100.0% |
| 2 | 04xy45965 | 1 | 100.0% |
| 3 | Sina (China) | 1 | 100.0% |
| 4 | Tongji University | 1 | 100.0% |
Download all institutions as CSV
About this data
Papers. Journal of Neuroimmune Pharmacology 2017 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Neuroimmune Pharmacology 2017”, https://lacuna.tiptreesystems.com/venue/journal-of-neuroimmune-pharmacology/2017.
Papers
| Title |
|---|
| Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro |